Erica Cai Named ALPCO’s Summer 2020 Diabetes Research Travel Grant Recipient

Erica Cai Named ALPCO’s Summer 2020 Diabetes Research Travel Grant Recipient

Today ALPCO announced Erica Cai from Harvard Medical School as the latest recipient of its Diabetes Research Travel Grant. Dr. Cai is a postdoctoral fellow from the Joslin Diabetes Center researching the mechanism of autoimmunity that leads to beta cell destruction and type 1 diabetes (T1D). Dr. - November 10, 2020 - ALPCO

New Rapid COVID-19 Point of Care Test

New Rapid COVID-19 Point of Care Test

Pepex Biomedical has diverted funds and resources to the development of Multiple Rapid COVID-19 Tests designed to accurately identify Antigens (diagnostic to detect active virus) and Antibodies (to determine immunity) in under 15 minutes with 95% accuracy. - November 09, 2020 - Pepex Biomedical, Inc.

Cayman Breaks Ground on State-of-the-Art Facility Projecting Future Growth in R&D

Cayman held a groundbreaking ceremony to start the buildout of a $20 million research and development facility at its headquarters in Ann Arbor, MI. - November 07, 2020 - Cayman Chemical Company

Adeoye Olukotun, M.D., MPH, FACC Joins Evon Medics, LLC as Advisor

Small business, Evon Medics, LLC today announced that pharmaceutical luminary and cardiologist, Dr. Adeoye Olukotun has joined the advisory board of the company in a formal advisory role. Dr. Olukotun is currently the Chief Executive Officer of CR Strategies, LLC, which consults on clinical trial... - November 01, 2020 - Evon Medics, LLC

3 Steps to Take Now to Reduce the Risk of Legionella in a Building’s Water System

After shutdowns due to coronavirus, businesses are reopening and there are steps building owners can take to check the water safety of their buildings. Hyperion provides Legionella water testing to help businesses reduce the risk of Legionella. - November 01, 2020 - Hyperion Biotechnology, Inc.

Volasertib, a Potential New Treatment for Rhabdomyosarcoma, Receives Orphan Drug Designation from the U.S. FDA

Volasertib, a Potential New Treatment for Rhabdomyosarcoma, Receives Orphan Drug Designation from the U.S. FDA

Oncoheroes Biosciences, a biotech focused on advancing new therapies for childhood cancer, today announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation (ODD) to volasertib for its use in treating pediatric rhabdomyosarcoma and other rare soft tissue sarcomas. Key... - October 15, 2020 - Oncoheroes Biosciences Inc.

3Sixty Pharma Solutions Announces Successful Approval of FDA Investigational New Drug Application

3Sixty Pharma Solutions LLC., www.3sixtypharma.com, has announced the successful submission to FDA, and approval of, an Investigational New Drug (IND) Application on behalf of one of its clinical-stage biotech clients. 3Sixty Pharma Solutions’ 360 Start-Up arm continues to be committed to... - October 15, 2020 - 3Sixty Pharma Solutions

Introducing EDI’s COVID-19 Nucleocapsid IgG Quantitative ELISA Kit

The EDI™ COVID-19 Nucleocapsid IgG Quantitative ELISA Kit is designed, developed & produced for the quantitative measurement of human anti-COVID-19 (anti-SARS-CoV-2) IgG antibody in serum. The test uses a series of calibrators & controls in order to determine a standard curve, which allows for specific, concentration-based results of patient samples, giving researchers & healthcare providers access to quantitative patient data in order to better understand a patient's current disease stage. - October 14, 2020 - Epitope Diagnostics, Inc.

Veralize Device Team Named Semi-Finalist for XPRIZE Rapid COVID-19 Testing

Team made up of 12-15 Molecular Diagnostics, African Biosciences Ltd. and Ahmadu Bello University has been selected as semi-finalist in the XPRIZE Rapid COVID-19 Testing competition. The patented rapid response diagnostic device designed by 12-15 Molecular Diagnostics can detect COVID-19 using saliva samples. By algorithmically analyzing the results with the 12-15 Molecular Diagnostics machine learning system, the test can provide 95% accuracy and early detection, even when there are no symptom - October 13, 2020 - African Biosciences Inc.

Evon Medics, LLC Has Been Awarded $1.7 Million Grant for the Evaluation of Its Medical Device for the Treatment of Opioid Use Disorder

Small business, Evon Medics, LLC today announced that it has been awarded a non-dilutive grant of $1.7 million for its Phase II SBIR (Small Business Innovation Research) clinical trials for the development and evaluation of its non-invasive Chemosensory-Based Orbitofrontal Cortex Training (CBOT)... - October 11, 2020 - Evon Medics, LLC

Cayman Receives SBIR Grant for Alzheimer’s Research

The National Institute on Aging (NIA) has awarded Cayman Chemical with a Phase II Small Business Innovation Research (SBIR) grant to develop an assay platform and novel antibodies to support the treatment, prevention, and early diagnosis of Alzheimer’s disease and other tauopathies. - October 10, 2020 - Cayman Chemical Company

Newly Renamed Healthcare Innovation Law Firm Emphasizes Diversity as Key to Exceptional Client Service

Nixon Law Group is pleased to announce that it is now Nixon Gwilt Law, recognizing co-founder Rebecca Gwilt’s leadership and contributions to the rapidly growing firm. Nixon Gwilt Law will continue to focus exclusively on healthcare innovation, serving clients in digital health, life sciences, and value-based care delivery. “Innovators never stop improving,” said co-founder Carrie Nixon. “This is true of our clients, and it’s true of our firm." - October 07, 2020 - Nixon Gwilt Law

Tornado Spectral Systems Achieves ISO 9001:2015 Certification

Tornado Spectral Systems Inc., a leading manufacturer of Raman analyzers for process monitoring, is proud to announce that it has achieved ISO 9001:2015 certification. Acquiring ISO 9001:2015 reinforces Tornado’s commitment to exceeding quality expectations and requirements of its... - October 03, 2020 - Tornado Spectral Systems

Legionnaires’ Disease Cases Lead to Legionella Water Testing

Hyperion Offers Testing to Identify If Legionella Bacteria Are Growing in a Building’s Water System. - October 03, 2020 - Hyperion Biotechnology, Inc.

FDA Grants Rare Pediatric Disease Designation (RPDD) to Volasertib for Rhabdomyosarcoma

FDA Grants Rare Pediatric Disease Designation (RPDD) to Volasertib for Rhabdomyosarcoma

Oncoheroes Biosciences, a biotech focused on advancing new therapies for childhood cancer, is pleased to announce that the United States Food and Drug Administration (FDA) has granted the designation of rare pediatric disease to volasertib, an investigational treatment for rhabdomyosarcoma. Key... - September 25, 2020 - Oncoheroes Biosciences Inc.

Ampersand Capital Partners Acquires American Laboratory Products Company

American Laboratory Products Company, Ltd. (ALPCO), a specialty in vitro diagnostics company, today announced the majority recapitalization of the company by Ampersand Capital Partners. Ampersand’s investment will be used to support ALPCO’s worldwide growth initiatives, including the... - September 21, 2020 - ALPCO

Testing is the Only Way to Confirm Water is Not Contaminated with Legionella Bacteria

Hyperion Biotechnology is offering complimentary Legionella water testing to local schools in San Antonio, Texas. - September 17, 2020 - Hyperion Biotechnology, Inc.

A US Patent for Personal Identity Management Using Blockchain Technology Was Granted to DNAtix

A US Patent for Personal Identity Management Using Blockchain Technology Was Granted to DNAtix

Digital DNAtix Ltd., the Israeli startup, announced today the grant of US patent No. US10673847B2 titled, “Systems and methods for user authentication based on a genetic sequence.” The patent is part of the company disruptive and innovative proprietary technology incorporating... - September 11, 2020 - Digital DNAtix Ltd.

Study Points to a New Unexplored Therapeutic Target for C9ORF72-mediated ALS

Study Points to a New Unexplored Therapeutic Target for C9ORF72-mediated ALS

A novel discovery from scientists at the ALS Therapy Development Institute (ALS TDI) is the first to indicate that asymmetric di-methylation of arginine could be a promising target for ALS therapies. - September 09, 2020 - ALS Therapy Development Institute

Paras Biopharmaceuticals Finland Oy Joins PSL Alliance and Its Global Membership to Promote Worldwide Reach Out for Paras’ Bioprocess Enzymes

Paras Biopharmaceuticals Finland Oy Joins PSL Alliance and Its Global Membership to Promote Worldwide Reach Out for Paras’ Bioprocess Enzymes

Paras Biopharmaceuticals Finland Oy (Paras Biopharma) is pleased to announce that it is now a member of the Pivotal Scientific Limited (PSL) Alliance, a network of companies operating within the biotechnology market. As part of the Company’s portfolio of microbial products, technologies and... - September 08, 2020 - Paras Biopharmaceuticals Finland Oy

Zifo RnD Solutions Partners with Aurigene Discovery Technologies for a Phase III Oncology Trial

Zifo RnD Solutions will be the Data Management Service provider for Aurigene Discovery Technologies’ large data driven Phase III oncology trial. - September 06, 2020 - Zifo RnD Solutions

3 Bros Grow Vertically Integrated Sustainable Cannabis Facility

3 Bros Grow Vertically Integrated Sustainable Cannabis Facility

3 Bros Grow announces sustainable vertically integrated cannabis cultivation, manufacturing, processing and distribution. - August 27, 2020 - 3 Bros Grow

New eClinical Platform Strategic Analysis & Competitive Landscape Report

Survey Quantifies eClinical Platform Use and Satisfaction and Identifies Dramatic Perceptual Changes - August 26, 2020 - Life Science Strategy Group, LLC

Grants Available for Undergraduate Students Seeking Research Experience

Cayman Biomedical Research Institute (CABRI) is now accepting applications from undergraduate students who have been offered an unpaid laboratory research position under an accredited principal investigator. Applications will be accepted until September 20, 2020, for awards to be distributed by November 2, 2020. Grants range from $2,000 - $5,000 and may be awarded as individual or group grants. - August 19, 2020 - Cayman Chemical Company

Harmful Bacteria May be Growing in a Building’s Water During COVID-19 Shutdowns

Legionella Water Testing Kits can help Businesses Reopen Safely. Hyperion Biotechnology now provides everything building owners need to collect samples for laboratory analysis to determine if Legionella bacteria are present. - August 15, 2020 - Hyperion Biotechnology, Inc.

Cayman and GenScript Partner to Offer Neoantigen Profiling and Synthesis Expertise

Cayman and GenScript have come together to create a complete package of neoantigen discovery services. Through combined efforts, MHC-associated peptides are identified and verified as immunogenic to guide peptide synthesis for vaccine development. “Cayman provides a complete workflow enabling... - August 15, 2020 - Cayman Chemical Company

New Study Highlights Exciting Potential of Umbilical Cord Tissue to Treat COVID-19

COVID-19 patients administered with Mesenchymal Stromal Cells (MSCs) from cord tissue all recover from disease. - Cord tissue cells shown to promote tissue repair and regeneration and support normal function of immune system. - Insception Lifebank is Canada’s first and largest cord blood... - August 07, 2020 - Insception

Help for Hotels as They Reopen - Hyperion Biotechnology Offers Legionella Water Testing

Hotel owners can test water systems to ensure guests’ safety from exposure to Legionella, a bacteria that can cause Legionnaires’ disease when spread through mist from a hotel’s water system. - August 07, 2020 - Hyperion Biotechnology, Inc.

Locus Performance Ingredients™ Launches Ferma™ Line of Sophorolipds (INCI: Glycolipids) to Replace Chemical Surfactants in Personal Care Formulations

Locus Performance Ingredients™, a new start-up developing biosurfactants through advanced fermentation, is launching its first product line to replace petrochemical surfactants in personal care formulations. Branded as Ferma™, the pure Sophorolipid series of biosurfactants provide safer and more sustainable ingredient options with 5-25 times better performance - enabling lower usage rates and reducing carbon footprint by a minimum of 37%. - August 05, 2020 - Locus Performance Ingredients

Microvascular Therapeutics Receives NIH SBIR Phase I Funds for Its Alzheimer Program

Microvascular Therapeutics (MVT), a biotechnology company based in Tucson, AZ, was recently awarded a Phase I Small Business Innovation Research grant from the National Institute of Aging (NIA), part of the National Institutes of Health (NIH). Wyatt Unger, MD, MBA, President and CEO of MVT said,... - August 03, 2020 - Microvascular Therapeutics

Microvascular Therapeutics Receives NIH SBIR Phase I Funds for Its Program to Treat Heart Attack

Microvascular Therapeutics (MVT), a biotechnology company based in Tucson, AZ, was recently awarded a Phase I Small Business Innovation Research grant from the National Heart, Lung, and Blood Institute (NHLBI), a part of the National Institutes of Health. Wyatt Unger, MD, MBA, President and CEO of... - July 31, 2020 - Microvascular Therapeutics

Locus FS Replaces Chemicals and Improves Sustainability in CPG Market with Launch of Performance Ingredients Company

Locus Fermentation Solutions is expanding its award-winning green technology into the Consumer Packaged Goods market with the launch of a new operating company, Locus Performance Ingredients that will replace toxic and palm-based chemicals and maximize product sustainability. - July 22, 2020 - Locus Performance Ingredients

Scientists at AbboMax, Inc. Created a TBNK Panel of Monoclonal Antibodies to Study SARS-CoV-2

Understanding of a host immune response to SARS-CoV-2 is extremely important. It was previously shown that the immune system of patients infected by SARS-CoV-2 is severely impaired. In order to better recognize how immune response is orchestrated, the TBNK (B-Cell, T-Cell, and natural killer cells) panel of antibodies created by AbboMax, Inc. can be employed. - July 22, 2020 - AbboMax, Inc.

Hyperion Biotechnology's Legionella Water Testing Services Can Help Businesses Reopen Safely

Coronavirus is not the only concern for business owners as they reopen. Another threat to health safety is water-borne bacteria called Legionella. - July 17, 2020 - Hyperion Biotechnology, Inc.

EUPROTEIN Launched the Supreme Humanly-Expressed Proteins to Help Research in SARS-CoV-2

EUPROTEIN Inc., the expert in mammalian expressed protein, has launched the full set of their top-quality recombinant proteins to help researchers around the world for their studies towards this global pandemic. These protein are expressed in human mammalian cells, which inherently is of superior quality compared to those expressed from E. Coli. - July 09, 2020 - EUPROTEIN Inc.

3 Bros Grow Announces Vertically Integrated Cannabis Genetics Nursery

3 Bros Grow Announces Vertically Integrated Cannabis Genetics Nursery

The 3 Bros Grow, a vertically integrated cannabis company, is moving into their first phase of greenhouse nursery to provide clean secured genetics, clones and teens to their operations. Luck #7, Cherry Bomb, Twizzlas, Grease Monkey and Chocolatina are some of the exclusive genetics available only from 3 Bros Grow. - July 01, 2020 - 3 Bros Grow

40 Women Researchers Receive $40,000 in Grants from Cayman and CABRI

Each year during Women’s History Month, Cayman provides travel grants to help women researchers attend conferences to benefit from and contribute to the larger scientific community. This year, because the COVID-19 pandemic caused most conferences to cancel or postpone and many academic labs to close, Cayman introduced a new program to help support women in research. A record high of forty women will benefit from Cayman’s Women in Research program this year. - July 01, 2020 - Cayman Chemical Company

R3 International Now Offering Stem Cell Therapy for Coronavirus in Mexico

R3 International Now Offering Stem Cell Therapy for Coronavirus in Mexico

R3 Stem Cell International is now offering stem cell therapy for coronavirus patients at its first rate Center in Tijuana, Mexico. Several treatment options are available that include up to 200 million stem cells, with pricing starting at only $2975. A growing body of research out of Europe,... - June 30, 2020 - R3 Stem Cell

On June 25, "How I Brewed This: Craft Brewer Series” to Feature Two Big Names in the Washington State Brewing Scene

On June 25, "How I Brewed This: Craft Brewer Series” to Feature Two Big Names in the Washington State Brewing Scene

The ALS Therapy Development Institute (ALS TDI) is excited to announce that on Thursday, June 25, they will be hosting the second episode of their new “How I Brewed This: Craft Brewer Series,” featuring Kevin Smith of Bale Breaker Brewing Company and Mike Smith of B.T. Loftus... - June 20, 2020 - ALS Therapy Development Institute

AdvantaPure(R) Now Offers GORE(R) STA-PURE(R) Pump Tubing, an Industry Staple for Single-Use Biotech and Pharmaceutical Processes

AdvantaPure is now a systems integrator of GORE STA-PURE Pump Tubing, Series PCS. The AdvantaPure team is expert at molding connections for tubing assemblies and can overmold GORE STA-PURE Pump Tubing as the pump element in biopharm and pharmaceutical assemblies. The overmolding process results in a smooth contact surface for optimal fluid flow. GORE STA-PURE Pump Tubing connects to any of AdvantaPure’s AdvantaSil(R) platinum-cured silicone tubing using overmolding technology. - June 17, 2020 - AdvantaPure

Bactronix Franchise Push Sees Unprecedented Success in Marketplace

Bactronix Franchise Push Sees Unprecedented Success in Marketplace

Bactronix, a science based microbial control company headquartered in Pennsylvania, has seen explosive growth since their latest franchise push announcement this spring. The company, specializing in environmentally safe, non-toxic sanitizing products and hospital-grade disinfection services, has... - June 11, 2020 - Bactronix

Bio Bench is Cooperating with Helixar Biosciences for the Europe and US Market

Bio Bench has started a partnership with Helixar Biosciences to support its Europe and North America market development. - June 09, 2020 - Bio Bench

Vascular BioSciences Announces New Preclinical Research Results Demonstrating Improved Pulmonary Hypertension and Sepsis Survival with CAR Peptide

CEO of Vascular BioSciences, David Mann, makes connection between current research and COVID-19 applications. - June 05, 2020 - Vascular BioSciences, Inc

AB BIOINNOVATIONS, Inc. Announces a Ground-Breaking Alternative to Antibiotics

AB BIOINNOVATIONS, Inc. Announces a Ground-Breaking Alternative to Antibiotics

The AB BIOINNOVATIONS, Inc. Antibacterial and Anti-inflammatory strips 1. Immediately resolve the very infection (including antibiotic-resistant bacteria), which its color indicator has detected; 2. AB BIO compound also immediately addresses inflammation at the site, thus suppressing pain, swelling, and discomfort. - June 03, 2020 - AB BIOINNOVATIONS, Inc.

Zeteo Biomedical Introduces ZEOx1 AquilaMD™ Ophthalmic Drug Delivery System

Zeteo Biomedical Introduces ZEOx1 AquilaMD™ Ophthalmic Drug Delivery System

Zeteo’s patient-centric ophthalmic delivery systems are designed for precise, self-administration of preservative free drugs and biopharmaceuticals. - June 01, 2020 - Zeteo Biomedical LLC

Experimentica Ltd. Announces the Successful Acquisition of the Ophthalmic Contract Research Division from Ophthy-DS, Inc.

Experimentica Ltd. Announces the Successful Acquisition of the Ophthalmic Contract Research Division from Ophthy-DS, Inc.

Experimentica Ltd., a leader in preclinical ophthalmic drug discovery services, announces the successful acquisition of the contract research division from Ophthy-DS, Inc., a Michigan-based preclinical contract research organization (CRO) specializing in non-regulated drug discovery services and medical device testing for ophthalmic indications. - May 22, 2020 - Experimentica Ltd

Zeteo Biomedical Receives NIH Award to Develop a Universal Nasal Flu Vaccine in Collaboration with the Iowa State University Nanovaccine Institute

Zeteo Biomedical Receives NIH Award to Develop a Universal Nasal Flu Vaccine in Collaboration with the Iowa State University Nanovaccine Institute

Vaccines that can be quickly manufactured, deployed and self-administered at global scale volumes is crucial to protect global populations against pandemic virus threats. - May 20, 2020 - Zeteo Biomedical LLC

Zeteo Biomedical Introduces ZEOx1 Orion(TM) Nasal Vaccine and Drug Delivery Systems

Zeteo Biomedical Introduces ZEOx1 Orion(TM) Nasal Vaccine and Drug Delivery Systems

Zeteo’s patient-centric delivery systems are designed for quick manufacturing to facilitate rapid deployment of drugs and vaccines to global populations. - May 14, 2020 - Zeteo Biomedical LLC

Minus K Technology Releases Its New CT-2 Ultra-Thin, Low-Frequency Passive Vibration Isolator

Minus K's New Ultra-Thin CT-2 Negative-Stiffness Passive Vibration Isolation Platform at Just 2-1/2 Inches in height Isolates Vibrations as Low as 1 Hertz Without the Need for Air or Electricity. - May 07, 2020 - Minus K Technology Inc.

Fast Track MHRA Approval for Vicore Pharma’s COVID-19 Clinical Trial Received in Record Time

Orphan Reach today announced that regulatory approval has been obtained for Vicore Pharma’s Phase II clinical trial with VP01 (C21) in patients with COVID-19, SARS CoV-2 infection. - May 04, 2020 - Orphan Reach

Press Releases 51 - 100 of 2,967